Cover Image
市場調查報告書

中國的中醫成藥市場

Research and Development Trend Forecast of Chinese Patent Medicine in China, 2014-2018

出版商 Huidian Research 商品編碼 316396
出版日期 內容資訊 英文 62 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的中醫成藥市場 Research and Development Trend Forecast of Chinese Patent Medicine in China, 2014-2018
出版日期: 2014年09月26日 內容資訊: 英文 62 Pages
簡介

2009年,中國的中醫成藥的累積生產量為180萬3,700噸,2010年以來維持急速成長,2010年的生產量達199萬7,700噸,2013年的生產量達310萬5,200萬噸。

本報告提供中國的中醫成藥市場相關調查分析、政策環境、市場規模、競爭格局、發展趨勢、主要企業等相關彙整。

第1章 中醫成藥概要

  • 概念
  • 產品的分類

第2章 中國的中醫成藥的發展環境

  • 中國的經濟發展環境
  • 關聯的產業政策、法律、法規、規格
  • 許多國家限制中醫成藥銷售

第3章 中國的中醫成藥產業現狀

  • 發展歷史
  • 全面發展現況
  • 中醫成藥產業的競爭格局

第4章 中國的中醫成藥市場分析與預測

  • 生產量
  • 銷售額
  • 市場區隔

第5章 中國的中醫成藥的進出口分析

  • 進口量/額:2011年∼2014年第一季
  • 出口量/額:2011年∼2014年第一季
  • 主要的進口商與外銷處:2014年第一季

第6章 中國的中醫成藥的主要企業

  • Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd
  • Jilin Xiuzheng Pharmaceutical Group
  • Yangtze River Pharmaceutical Group
  • Chongqing Taiji Industry (Group) Co., Ltd
  • China Resources Sanjiu Medical & Pharmaceutical Co., Ltd

第7章 中國的中醫成藥的今後發展趨勢

第8章 中國的中醫成藥產業相關專家的投資提案

  • SWOT分析
  • 市場策略分析
目錄

Research and Development Trend Forecast of Chinese Patent Medicine in China, 2014-2018 analyses the policy environment, market scale, competition pattern, development trend and key enterprises in Chinese patent medicine industry in China.

The implement of New Medical Reform Plan provides solid guarantee for the development of Chinese patent medicine, but also National Essential Drugs List lists large batch of Chinese Patent Medicine, which drives the continual expansion of Chinese patent medicine market scale in China effectively. In 2009, the cumulative output of Chinese patent medicine was 1.8037 million ton, since 2010, the Chinese patent medicine industry has been maintaining fast growth, the cumulative output was 1.9977 million ton in 2010 and 3.1052 million ton in 2013.

With the era development, the health concept has been given new connotation, the third state (Sub-health state) and its harm has cause people's extensive concerns; and with the improvement of living standard, people long for life quality and long life increasingly. Human medical model has been transformed from the pure "biomedical model" to the "biological-psychology-sociological model", and from treatment of disease to the model combining prevention, health, treatment and recovery.

The chemical drugs bite off more than they can chew in this field, while the profound Chinese patent medicine are causing people's attention and playing important role in health increasingly, and the rush of health cult provides valuable opportunities and extensive space for Chinese patent medicine development in China.

Table of Contents

1. Overview of Chinese Patent Medicine

  • 1.1. Concept
  • 1.2. Product Classification

2. Development Environment of Chinese Patent Medicine in China

  • 2.1. Economic Development Environment in China
  • 2.2. Related Industrial Policies, Law, Regulations and Standards
    • 2.2.1. Influence on Chinese Patent Medicine by New Medical Reform Policy
    • 2.2.2. Chinese Patent Medicine Development in "the 12th Five Years Plan" Period
    • 2.2.3. Policy Summary of Medicine Industry in China
    • 2.2.4. Related Industrial Standards
  • 2.3. Many Countries with Restriction on Sales of Chinese Patent Medicine

3. Current Status of Chinese Patent Medicine Industry in China

  • 3.1. Development History
  • 3.2. Current Status of Overall Development
    • 3.2.1. Current Status of Chinese Patent Medicine Development in China
    • 3.2.2. Current Status of Chinese Patent Medicine Trade in China
  • 3.3. Competition Pattern in Chinese Patent Medicine Industry

4. Analysis and Forecast on Chinese Patent Medicine Market Scale in China

  • 4.1. Output
    • 4.1.1. Output Analysis
    • 4.1.2. Output Forecast
  • 4.2. Sales
    • 4.2.1. Sales Analysis
    • 4.2.2. Sales Structure in 2013
    • 4.2.3. Sales Forecast
  • 4.3. Market Segmentation
    • 4.3.1. Cardio-cerebrovascular Diseases
    • 4.3.2. Tumor diseases
    • 4.3.3. Respiratory Diseases
    • 4.3.4. Bone Diseases

5. Analysis on Import and Export of Chinese Patent Medicine in China

  • 5.1. Import Volume and Value in 2011- the First Half Year of 2014
  • 5.2. Export Volume and Value in 2011- the First Half Year of 2014
  • 5.3. Main Import Sources and Export Destinations by Trade Value in the First Half Year of 2014

6. Main Chinese Patent Medicine Enterprises in China

  • 6.1. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd
    • 6.1.1. Company Profile
    • 6.1.2. Competitiveness
    • 6.1.3. Business Performance
    • 6.1.4. Development Strategy
    • 6.1.5. Main Business and Products
  • 6.2. Jilin Xiuzheng Pharmaceutical Group
    • 6.2.1. Company Profile
    • 6.2.2. Competitiveness
    • 6.2.3. Business Performance
    • 6.2.4. Main Products
  • 6.3. Yangtze River Pharmaceutical Group
    • 6.3.1. Company Profile
    • 6.3.2. Competitiveness
    • 6.3.3. Business Performance
    • 6.3.4. Development Strategy
    • 6.3.5. Main Products
  • 6.4. Chongqing Taiji Industry (Group) Co., Ltd
    • 6.4.1. Company Profile
    • 6.4.2. Competitiveness
    • 6.4.3. Business Performance
    • 6.4.4. Development Strategy
    • 6.4.5. Main Products
  • 6.5. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd
    • 6.5.1. Company Profile
    • 6.5.2. Competitiveness
    • 6.5.3. Business Performance
    • 6.5.4. Development Strategy
    • 6.5.5. Main Business and Products

7. Future Development Trend of Chinese Patent Medicine in China

8. Expert Suggestion on investment in Chinese Patent Medicine Industry

  • 8.1. SWOT Analysis
  • 8.2. Market Strategy Analysis
Back to Top